OCS Oculis Holding AG
Healthcare$29.93+1.49%ClosedMarket Cap: $1.71B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
6.94
P/S
2620.11
EV/EBITDA
-14.85
DCF Value
$1.91
FCF Yield
-4.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
-2889.4%
Operating Margin
-16741.0%
Net Margin
-18861.3%
ROE
-57.1%
ROA
-39.1%
ROIC
-42.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-22.4M | $-29.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-20.9M | $-23.3M | $— | — |
| FY null | $0.00 | NaN% | $-79.1M | $-94.5M | $— | — |
| Q3 null | $243.0K | 100.0% | $-20.3M | $-16.9M | $— | — |
| Q2 null | $261.0K | -5612.3% | $-20.8M | $-25.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-20.0M | $-33.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-17.3M | $-28.7M | $— | — |
| FY null | $686.0K | -7492.3% | $-73.2M | $-85.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-18.1M | $-20.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-22.5M | $-20.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-15.3M | $-16.1M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-12.2M | $-12.5M | $-0.34 | — |